MoonLake Immunotherapeutics (MLTX) short interest & options flow
NASDAQMLTX cost to borrow surges 135% in one week to 0.55%, though remains low in absolute terms as short interest climbs 27% over the same period to 12.7% of free float.
- Market cap
- $1.07B
- Next earnings
- 25 Feb 2027
Key data as of 10 Nov 2026
Latest signals on MLTX
- Cost to Borrow
MLTX cost to borrow surges 135% in one week to 0.55%, though remains low in absolute terms as short interest climbs 27% over the same period to 12.7% of free float.
- Short Interest
MLTX short interest climbed 27.1% over one week to 12.7% of free float, driven by heavy short accumulation despite analyst price targets averaging $28.54, well above the current $11.70 price.
MLTX news and analysis
RSSNo long-form analysis yet for MLTX. Pulse alerts and the live data picture are available on ORTEX.
Open MLTX on ORTEX →Want the live picture for MLTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MLTX — free to start on ORTEX.
Sign up for free →Open MLTX on ORTEX